phospho-PLB (Ser16) Polyclonal Antibody, APC-Cy7 Conjugated, APC/Cy7, Rabbit

Artikelnummer: BSS-BS-2984R-APC-CY7
Artikelname: phospho-PLB (Ser16) Polyclonal Antibody, APC-Cy7 Conjugated, APC/Cy7, Rabbit
Artikelnummer: BSS-BS-2984R-APC-CY7
Hersteller Artikelnummer: bs-2984R-APC-Cy7
Alternativnummer: BSS-BS-2984R-APC-CY7-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF
Spezies Reaktivität: Human, Mouse, Rat
Konjugation: APC/Cy7
Alternative Synonym: Phospholamban phospho S16, p-Phospholamban phospho S16, p-PLBS16, Cardiac phospholamban, CMD1P, PLB, PLN, PPLA_HUMAN.
Defects in PLN are the cause of cardiomyopathy dilated type 1P (CMD1P) . Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.Defects in PLN are the cause of cardiomyopathy familial hypertrophic type 18 (CMH18) . CMH18 is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
Klonalität: Polyclonal
Konzentration: 1ug/ul
NCBI: 5350
Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic phosphopeptide derived from human Cardiac phospholamban around the phosphorylation site of Ser16
Target-Kategorie: phospho-PLB (Ser16)
Application Verdünnung: IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)